full.am
  • am
  • en
  • ru
USD 389.56
EUR 444.14
RUB 4.71

Cagrilintide CAS 1415456-99-3 5MG 10MG Loss Weight Peptide

  • Кентрон
  • 27/12/2024 06:51

Оффис

[email protected]

  • Название компании

    Cagrilintide CAS 1415456-99-3 5MG 10MG Loss Weight Peptide

  • Рабочая область

    Услуги и Быт

  • График

    Полный день

  • Образование

    Среднее

  • Опыт

    Container: Glass Vial

    Presentation: Lyophilized Powder

    Molecular formula: C194H312N54O59S2

    Molecular weight: 4409.01 g/mol

    PubChem CID: 171397054

    CAS Number: 1415456-99-3

    Research Applications: Weight Loss and Obesity

    Type 2 Diabetes

    Glucose Regulation

    Cagrilintide is a novel, long-acting acylated amylin analogue that functions as a non-selective agonist for amylin receptors (AMYR) and the calcitonin G protein-coupled receptor (CTR). Cagrilintide is structurally similar to pramlintide but with key differences, including the lipidation of the N-terminal lysine and substitutions of three amino acids (N14E, V17R, and P37Y). These modifications are designed to improve stability and efficacy. Cagrilintide has shown promise in obesity research by significantly reducing food intake and inducing weight loss.



    Tirzepatide CAS 2023788-19-2

    Semaglutide CAS 910463-68-2

    Retatrutide CAS 2381089-83-2

    Liaglutide CAS 204656-20-2

    Whatsapp/Telegram:+86 13363081709

    [email protected]

  • Пол

  • Возраст

  • Описание

  • Container: Glass Vial

    Presentation: Lyophilized Powder

    Molecular formula: C194H312N54O59S2

    Molecular weight: 4409.01 g/mol

    PubChem CID: 171397054

    CAS Number: 1415456-99-3

    Research Applications: Weight Loss and Obesity

    Type 2 Diabetes

    Glucose Regulation

    Cagrilintide is a novel, long-acting acylated amylin analogue that functions as a non-selective agonist for amylin receptors (AMYR) and the calcitonin G protein-coupled receptor (CTR). Cagrilintide is structurally similar to pramlintide but with key differences, including the lipidation of the N-terminal lysine and substitutions of three amino acids (N14E, V17R, and P37Y). These modifications are designed to improve stability and efficacy. Cagrilintide has shown promise in obesity research by significantly reducing food intake and inducing weight loss.



    Tirzepatide CAS 2023788-19-2

    Semaglutide CAS 910463-68-2

    Retatrutide CAS 2381089-83-2

    Liaglutide CAS 204656-20-2

    Whatsapp/Telegram:+86 13363081709

    [email protected]

Share